Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients

about

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients

Item

http://www.wikidata.org/entity/Q57168424

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Estimated lifetime survival be ...... iagnosed glioblastoma patients

@en

Estimated lifetime survival be ...... iagnosed glioblastoma patients

@nl

type

Item

label

Estimated lifetime survival be ...... iagnosed glioblastoma patients

@en

Estimated lifetime survival be ...... iagnosed glioblastoma patients

@nl

prefLabel

Estimated lifetime survival be ...... iagnosed glioblastoma patients

@en

Estimated lifetime survival be ...... iagnosed glioblastoma patients

@nl

P1476

Estimated lifetime survival be ...... iagnosed glioblastoma patients

@en

P2093

Bruce Cm Wang

http://www.w3.org/2001/XMLSchema#string

Gregory F Guzauskas

http://www.w3.org/2001/XMLSchema#string

Marc Salzberg

http://www.w3.org/2001/XMLSchema#string

P2860

Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Tumor treating fields: a novel treatment modality and its use in brain tumors

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data.

Disruption of cancer cell replication by alternating electric fields.

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields.

Conditional probability of survival in patients with newly diagnosed glioblastoma

The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK.

P304

CNS23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/CNS-2018-0010

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30124334

http://www.w3.org/2001/XMLSchema#string

P932

6200060

http://www.w3.org/2001/XMLSchema#string